Press Releases
- Myriad Genetics Announces New Executive Vice President of International Operations
- Myriad Genetics Elects Former Roche Molecular Systems CEO Heiner Dreismann to Its Board of Directors
- Myriad Genetics Announces New, Convenient OnDose(TM) Sampling Kit
- Myriad Study Shows PTEN Gene is Useful in Predicting Prostate Cancer Recurrence
- Myriad Study Reveals Patients Receive Suboptimal Dosing With Chemotherapy Regimens of FOLFOX6 and FOLFOX6 Plus Avastin
- Myriad Genetics to Present at the Seventh Annual Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology (ASCO)
- Myriad Genetics to Present at the 28th Annual J.P. Morgan Healthcare Conference
- Myriad Genetics Launches Public Awareness Campaign in Five Midwest States to Reach Women with Increased Risk of Hereditary Breast and Ovarian Cancer
- Myriad Genetics to Present At The Morgan Stanley Global Healthcare Conference
- Myriad Pharmaceuticals Acquires Novel HIV Drug, Bevirimat
- Myriad Applauds New ACOG Guidelines for Hereditary Breast and Ovarian Cancer
